Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that the company granted equity awards to...
Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that the company granted equity awards to...
NORTHLAKE, Texas, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ:FARM) ( “Farmer Brothers” or the “Company”) today announced that the Company...
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that on December 29, 2022, and in connection with the previously announced... | January 4, 2023
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on December 30,...
/PRNewswire/ -- LivePerson, Inc. (Nasdaq: LPSN) is providing confirmatory notice, pursuant to the requirements of Nasdaq Listing Rule 5635(c)(4), of recent...